Groundbreaking MS research to be announced April 10-17th

From the Medical News Today website (article dated April 14th 2010, see under Links to the right)

At the American Academy of Neurology (AAN) Annual meeting, among other things, a potential new drug for the treatment of MS, and surprising trends showing a reduction in the disease’s severity…

Teriflunomide, is an investigational oral medication for relapsing-remitting multiple sclerosis (RRMS)… The study analyzed teriflunomide added to ongoing treatment with glatiramer acetate, a currently prescribed medication, and determined that teriflunomide was safe and effective as part of combination therapy.

And most important of all:

MRI studies revealed that teriflunomide also proved to be effective at reducing the size and volume of lesions on the brain.

“While our study was designed to evaluate the safety of teriflunomide, we determined that in addition to being safe it was also effective in reducing the size and number of lesions in people with RRMS,” said Aaron Miller, MD, Professor of Neurology, and Medical Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai School of Medicine.

“Further data are required to evaluate efficacy of this combination therapy, but the results are promising.”

One can just comment…that it really sounds like the data is promising! if this drug manages to REDUCE the size AND volume of lesions on the brain…wow!


1 Comment (+add yours?)

  1. maggsbunny
    Apr 16, 2010 @ 00:05:22

    There is so much going on in the field at the moment – it is very heartening!


Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: